Back to results
US 7,732,407 B2Granted
Method for treatment of demyelinating central nervous system disease
OwnerSamuel F. Hunterinventor
Life of this patent
Estimating the term…
Abstract
A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM-CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.
Claims24
A method for treating demyelinating central nervous system diseases in a subject, comprising:
- determining the presence of neural demyelination in a subject;
- and
- administering to a subject in need thereof a composition comprising an effective demyelination-inhibiting amount of a granulocyte-macrophage colony stimulating factor.
A method of treating multiple sclerosis comprising:
- determining the presence of neural demyelination in a subject;
- and
- administering to a subject in need thereof a composition comprising an effective demyelination-inhibiting amount of a granulocyte-macrophage colony stimulating factor.
A method of improving demyelinating central nervous system disease treatment in a subject, comprising:
- determining the presence of neural demyelination in a subject;
- and
- administering to a subject in need thereof a composition comprising an effective demyelination-inhibiting amount of a granulocyte-macrophage colony stimulating factor.
Dependencies are inferred from the claim text.